The cannabis plant contains hundreds of cannabinoids, terpenes, and flavonoids. Yet only a couple of cannabinoids and a handful of terpenes are widely known. The psychological effects and medicinal benefits of the major cannabis phytocannabinoids THC and CBD are the most well known. But we’re now beginning to uncover more information about the minor cannabinoids of cannabis as well. These less abundant but still very important cannabinoids include CBG, CBC, CBN, CBDa, THCv, THCa, and Delta-8.
Our special guest speaker is Chris Emerson, Ph.D., the Founder, Chief Scientist, and CEO of LEVEL. Chris will give an insightful presentation on the benefits of emerging minor cannabinoids and the process of extracting them. LEVEL creates unique, targeted effects-based cannabis products by formulating cannabinoids in ratios not accessible from the plant alone.
Wed, Oct 6, 2021 · 5:00 PM
Pacific Time (US & Canada)
Duration: 1 hour
Who can attend
Dial-in available? (listen only)
Please register for this Webinar to view the dial-in info.
Hosted By Farmacy Cannabis Lecture Series
The Farmacy Cannabis Lecture Series was designed to deliver a small and in-depth dose of cannabis education. Each session will feature industry leaders, doctors, and researchers who will provide valuable information and insight to make audience members better-informed cannabis consumers.
Chris Emerson, Ph.D. is the founder and CEO of LEVEL—a science-driven cannabis company on the cutting edge of cannabinoid research and innovation. He is passionate about guiding humans through the journey, that is cannabis. Through education and...